| Financial Year |
March 31 2023 |
| Monetary Funds |
972,247,926.26 |
| Held-for-trading Financial Assets |
100,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
148,410,011.44 |
| Advances to Suppliers |
7,921,017.68 |
| Other Receivables |
65,982,594.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
71,313,554.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,128,663.21 |
| Total Current Assets |
1,376,032,232.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
13,237,492.20 |
| Fixed Assetes |
385,362,412.68 |
| Under-construction Projects |
1,641,367.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
47,814,533.18 |
| R&D expenses |
-- |
| Goodwill |
57,632,744.00 |
| Long-Term Deferred and Prepaid Expenses |
6,762,318.86 |
| Deferred Income Tax Assets |
32,520,237.48 |
| Other Non-Current Assets |
43,943,451.41 |
| Sub-Total of Non-Current Assets |
1,008,867,091.71 |
| Total Assets |
2,384,899,323.92 |
| Short-Term Loans |
218,425,972.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
12,542,884.96 |
| Accounts Payable |
90,612,785.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,363,121.32 |
| Taxes Payable |
12,545,769.50 |
| Interest Payable |
-- |
| Dividend Payable |
13,017,020.94 |
| Other payables |
66,206,478.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
121,469,860.07 |
| Other Current Liabilities |
5,321,730.53 |
| Sub-Total of Current Liabilities |
559,089,190.93 |
| Long-term Loans |
55,076,388.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
18,215,955.71 |
| Special Payable |
-- |
| Estimatied Liabilities |
15,781,833.49 |
| Deferred Income Tax Liabilities |
33,627,768.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
138,490,812.91 |
| Total Liabilities |
697,580,003.84 |
| Paid-In Capital(Or Share Stock) |
498,344,263.00 |
| Capital Surplus |
841,730,206.24 |
| Surplus Reserve |
68,888,743.01 |
| LESS:Treasury Stock |
17,549,035.49 |
| Undistributed Profits |
191,559,337.78 |
| Minority Stockholder's Interest |
104,345,805.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,582,973,514.54 |
| Owner's Equity（Stockholder's Equity） |
1,687,319,320.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,384,899,323.92 |
